Search Results 371-380 of 16179 for Bacteriostatic
This type of medicine adds complementary and alternative medicine (CAM) practices to mainstream medicine.
Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The primary objective of the study is to compare sacituzumab tirumotecan combined with ...
This is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with advanced or metastatic ER+ ...
Integrative medicine combines complementary and alternative medicine (CAM) practices with conventional medicine.
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.
Medical Professionals news and the latest information about Cancer.
Research. Mayo Clinic researchers do studies about complementary and integrative medicine to learn which treatments and practices work and to share findings ...
About this study. Panobinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying ...
The purpose of this study is to compare the effectiveness of gilteritinib to midostaurin in patients receiving standard combination chemotherapy for FLT3 AML.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.